Medicines and Prescribing
Policies and Position Statements
This section of the website is to allow users easy access to medicines related PCT policies or positioning statements. PCT policies will have been ratified by the relevant committee and should be considered mandatory for all staff.
The positioning statements for particular drug interventions are advisory, based on a formal review of the published evidence of both clinical and cost-effectiveness as well as safety.
The purpose of positioning statements is to provide clinicians with a PCT view on the suitability of new drug treatments for use within out patient population.
Guideline for the prescribing of Gluten-free products within primary care on NHS prescriptions
(March 2011)  (108k)
SSPCT Guidance for home blood glucose monitoring (20k)
Calculation chart for prescribing insulin (32k)
SSPCT Guidance for the use of Oral Nutritional Supplements for Adults (August 10 review) (69k)
Circadin Guidance SSPCT (32k)
Clarification of Hepatitis B Vaccine Payments (29k)
Grazax Guidance SSPCT (March 09 review) (65k)
Sativex Guidance SSPCT (March 09 review) (53k)
Antioxidant vitamin and mineral supplements for age-related macular degeneration (February 10) (49k)
Glucosamine Guidance (February 09 review) (63k)
Prescribing Drugs for the Treatment of Erectile Dysfunction (February 08 review) (42k)
Blood Glucose Testing Strips (November 07 review) (42k)
Self Blood Glucose Monitoring (38k)
Note : All the documents contained within the site are available for download in PDF format. You can download the Adobe Reader from the Adobe website.
|
